Seeking Alpha

The Patent Office issues a notification of a Notice of Allowance for Amarin's (AMRN) application...

The Patent Office issues a notification of a Notice of Allowance for Amarin's (AMRN) application for a patent that's used in the company's Vascepa product, which is a prescription formulation made up of fish oils and is used to treat high levels of triglycerides. The Patent Office issues NOAs after deciding that a patent can be granted. The FDA approved Vascepa in July. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector